EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Analyst Earnings Estimates
TSX-V:EVMT - TSX Venture Exchange - CA30053H1055 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 150K -62.50% | 18.31M 12,106.67% | 62.628M 242.04% | 62.835M 0.33% | |
| EBITDA YoY % growth | -840K 30.58% | 230K 127.38% | -3.037M -1,420.43% | 2.089M 168.78% | |
| EBIT YoY % growth | -840K 33.33% | -610K 27.38% | -5.522M -805.25% | N/A | |
| Operating Margin | -560.00% | -3.33% | -8.82% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 75.00% | -0.05 -400.00% |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 10.011M -49.05% | % | ||
| Q2 2024 Q2Q % growth | 10.539M -36.42% | % | ||
| Q1 2024 Q2Q % growth | 12.071M 12.99% | % | ||
| Q4 2023 Q2Q % growth | 15.722M -53.20% | % | ||
| Q3 2023 Q2Q % growth | 19.648M 95.61% | % | ||
| Q2 2023 Q2Q % growth | 16.575M 64.95% | % | ||
| Q1 2023 Q2Q % growth | 10.683M 26.26% | % | ||
| Q4 2022 Q2Q % growth | 33.595M 535.46% | % | ||
| Q3 2022 Q2Q % growth | 10.044M 152.76% | % | ||
| Q2 2022 Q2Q % growth | 10.049M 1,602.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |